Taysha Gene Therapies, Inc. TSHA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s restricted cash?
- Taysha Gene Therapies, Inc. (TSHA) reported restricted cash of $449K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s restricted cash changed year-over-year?
- Taysha Gene Therapies, Inc.'s restricted cash decreased by 0.0% year-over-year, from $449K to $449K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s restricted cash?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s restricted cash has grown at a -35.8% compound annual growth rate (CAGR), from $2.64M to $449K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.